BioSpace News Archive

Bariatric has become a popular field of medicine in the last two decades. The impelling volume of obese population, especially in the U.S., Europe, and a few Asian countries has given impetus to this field of medical science.

Prematurity is one of the leading causes of neonatal deaths worldwide. More than one million newborns die of prematurity each year and those who are able to survive suffer from several disabilities.

Having a pet is always good for the people. The get to share emotional moments with the pets and can overcome issues like anxiety and depressions.

With better infrastructure for research, the ability to perform sophisticated studies and analyses has become better over the years.

The global urinary protein reagents market is projected to develop at a considerable pace in the coming years of the forecast period of 2019 to 2027.

Cosmo Pharmaceuticals NV announced the FDA approval of GI Genius™ intelligent endoscopy system, its revolutionary device for lesion detection during colonoscopy.

REGEN-COV rapidly protected household contacts from exposure to SARS-CoV-2 at home, with 72% protection against symptomatic infections in the first week, and 93% in subsequent weeks

BioInvent International AB announced that Oncurious NV has presented data from a phase I dose escalation study of TB-403 in pediatric subjects with relapsed or refractory medulloblastoma at the annual meeting of the American Association for Cancer Research.

Airway Therapeutics, Inc., a biopharmaceutical company developing a new class of biologics to break the cycle of injury and inflammation for patients with respiratory and inflammatory diseases, announced the U.S. Food and Drug Administration has accepted its Investigational New Drug application to develop AT-100 as a treatment for COVID-19.

Abcam, a global innovator in life science reagents and tools, and MEDx Translational Medicine, formerly QIAGEN Translational Medicine Co., Ltd., a company dedicated to developing companion diagnostics and precision medicine, announced the extension of their strategic partnership to include the co-development and commercialization of key companion and in vitro diagnostic kits for MEDx to supply to the Chinese market.